PNC FINANCIAL SERVICES GROUP, INC.

Holdings History for ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

Symbol: ORMP on Nasdaq
Investment type: Equity / Common Stock par value $0.012 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$60,420	21,200	-2,000	-8.6%	$2.85	Q4 2025
30 Sep 2025	0%	0%	$61,248	23,200	0		$2.64	Q3 2025
30 Jun 2025	0%	-0%	$52,200	23,200	-3,000	-11%	$2.25	Q2 2025
31 Mar 2025	0%	0%	$56,068	26,200	0		$2.14	Q1 2025
31 Dec 2024	0%	0%	$63,404	26,200	0		$2.42	Q4 2024
30 Sep 2024	0%	0%	$63,928	26,200	0		$2.44	Q3 2024
30 Jun 2024	0%	0%	$67,334	26,200	0		$2.57	Q2 2024
31 Mar 2024	0%	0%	$76,504	26,200	0		$2.92	Q1 2024
31 Dec 2023	0%	-0%	$60,522	26,200	-975	-3.6%	$2.31	Q4 2023
30 Sep 2023	0%	+0%	$70,927	27,175	+3,000	+12%	$2.61	Q3 2023
30 Jun 2023	0%	0%	$86,547	24,175	0		$3.58	Q2 2023
31 Mar 2023	0%	+0%	$52,702	24,175	+2,000	+9%	$2.18	Q1 2023
31 Dec 2022	0%	+0%	$266,765	22,175	+975	+4.6%	$12.03	Q4 2022
30 Sep 2022	0%	0%	$137,000	21,200	0		$6.46	Q3 2022
30 Jun 2022	0%	0%	$97,000	21,200	0		$4.58	Q2 2022
31 Mar 2022	0%	0%	$183,000	21,200	0		$8.63	Q1 2022
31 Dec 2021	0%	0%	$303,000	21,200	0		$14.29	Q4 2021
30 Sep 2021	0%	0%	$466,000	21,200	0		$21.98	Q3 2021
30 Jun 2021	0%	0%	$284,000	21,200	0		$13.40	Q2 2021
31 Mar 2021	0%	0%	$215,000	21,200	0		$10.14	Q1 2021
31 Dec 2020	0%	0%	$90,000	21,200	0		$4.25	Q4 2020
30 Sep 2020	0%	0%	$55,000	21,200	0		$2.59	Q3 2020
30 Jun 2020	0%	0%	$75,000	21,200	0		$3.54	Q2 2020
31 Mar 2020	0%	0%	$64,000	21,200	0		$3.02	Q1 2020
31 Dec 2019	0%	0%	$109,000	21,200	0		$5.14	Q4 2019
30 Sep 2019	0%	0%	$68,000	21,200	0		$3.21	Q3 2019
30 Jun 2019	0%	0%	$76,000	21,200	0		$3.58	Q2 2019
31 Mar 2019	0%	0%	$77,000	21,200	0		$3.63	Q1 2019
31 Dec 2018	0%	0%	$64,000	21,200	0		$3.02	Q4 2018
30 Sep 2018	0%	0%	$103,000	21,200	0		$4.86	Q3 2018
30 Jun 2018	0%	0%	$158,000	21,200	0		$7.45	Q2 2018
31 Mar 2018	0%	0%	$138,000	21,200	0		$6.51	Q1 2018
31 Dec 2017	0%	0%	$191,000	21,200	0		$9.01	Q4 2017
30 Sep 2017	0%	0%	$211,000	21,200	0		$9.95	Q3 2017
30 Jun 2017	0%	0%	$165,000	21,200	0		$7.78	Q2 2017
31 Mar 2017	0%	0%	$130,000	21,200	0		$6.13	Q1 2017
31 Dec 2016	0%	0%	$130,000	21,200	0		$6.13	Q4 2016
30 Sep 2016	0%	+0%	$154,000	21,200	+7,393	+54%	$7.26	Q3 2016
30 Jun 2016	0%	0%	$115,000	13,807	0		$8.33	Q2 2016
31 Mar 2016	0%	+0%	$92,000	13,807	+11,089	+408%	$6.66	Q1 2016
31 Dec 2015	0%	0%	$23,000	2,718	0		$8.46	Q4 2015
30 Sep 2015	0%	0%	$15,000	2,718	0		$5.52	Q3 2015
30 Jun 2015	0%	+0%	$15,000	2,718	+2,718	NEW	$5.52	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.